Cargando…
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study
Autores principales: | Rambaldi, Alessandro, Iurlo, Alessandra, Vannucchi, Alessandro M., Noble, Richard, von Bubnoff, Nikolas, Guarini, Attilio, Martino, Bruno, Pezzutto, Antonio, Carli, Giuseppe, De Muro, Marianna, Luciani, Stefania, McMullin, Mary Frances, Cambier, Nathalie, Marolleau, Jean-Pierre, Mesa, Ruben A., Tibes, Raoul, Pancrazzi, Alessandro, Gesullo, Francesca, Bettica, Paolo, Manzoni, Sara, Di Tollo, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387307/ https://www.ncbi.nlm.nih.gov/pubmed/32047238 http://dx.doi.org/10.1038/s41375-020-0735-y |
Ejemplares similares
-
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program
por: Rambaldi, Alessandro, et al.
Publicado: (2021) -
An agenda for future research projects in polycythemia vera and essential thrombocythemia
por: Barbui, Tiziano, et al.
Publicado: (2020) -
Polycythemia vera treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018) -
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views
por: Tefferi, Ayalew, et al.
Publicado: (2021) -
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
por: Iurlo, Alessandra, et al.
Publicado: (2020)